Find the latest Quest Diagnostics news related to customer service below. We do our best to screen the news provided here for relevance and accuracy, but the links to articles found here are from 3rd parties so occassionally less pertinent materials get published. Please feel free to contact us to report other relevant articles, or to let us know of any material that should be removed.
If you are a frequent customer of commercial laboratory testing services in North America, you probably have been offered one or more diagnostic products of one of its leading providers– Quest Diagnostics Inc. (DGX). Apart from the U.S., this company ...
Quest Diagnostics Inc. (DGX - Analyst Report) is scheduled to report its fourth-quarter and full-year 2014 results before the opening bell on Jan 29. Last quarter, Quest Diagnostics had posted a positive earnings surprise of 1.85%. Let's see how things ...
On Jan 13, Zacks Investment Research upgraded Quest Diagnostics Inc. (DGX - Analyst Report) to a Zacks Rank #1 (Strong Buy). Why the Upgrade? Of late, Quest Diagnostics has been witnessing rising earnings estimates on the back of healthy third-quarter ...
New Jersey-based diagnostic testing, information and services provider Quest Diagnostics Inc.'s (DGX - Analyst Report) Simplexa Flu A/B & RSV Direct Kit recently won the U.S. Food & Drug Administration (FDA) clearance for testing eight additional ...
Quest Diagnostics Inc logo Quest Diagnostics (NYSE:DGX) was upgraded by equities researchers at Deutsche Bank from a “hold” rating to a “buy” rating in a research report issued on Thursday, TheFlyOnTheWall.com reports. The firm currently has a $75.00 ...
Quest Diagnostics logo Shares of Quest Diagnostics (NYSE:DGX) have been given a consensus recommendation of “Hold” by the sixteen analysts that are covering the company, StockRatingsNetwork.com reports. One analyst has rated the stock with a sell ...
Quest Diagnostics Inc logo Zacks restated their neutral rating on shares of Quest Diagnostics (NYSE:DGX) in a research note issued to investors on Thursday. The firm currently has a $67.00 price target on the stock. Zacks' analyst wrote, “Quest ...
Quest Diagnostics' (DGX - Analyst Report) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations of $1.10 exceeded the Zacks Consensus Estimate by a couple of cents and the year-ago number by 7.8%. Adjusted EPS in the ...
Quest Diagnostics logo Quest Diagnostics Inc (NYSE:DGX) issued an update on its FY14 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $4.03-4.07 for the period, compared to the Thomson Reuters ...
Quest Diagnostics Inc. (DGX - Analyst Report) is scheduled to report its third-quarter 2014 results before the opening bell on Oct 23. Last quarter, Quest Diagnostics had posted a positive earnings surprise of 1.89%. Let's see how things are shaping up ...
MADISON, N.J., Oct. 7, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2014 results on Thursday, October 23, 2014, before the market opens.
Quest Diagnostics logo Quest Diagnostics (NYSE:DGX) has been given a “BBB+” credit rating by analysts at Morningstar. The firm's “BBB+” rating indicates that the company is a moderate default risk. They also gave their stock a three star rating ...
FOR APPELLANTS: Nicole M. Acchione, Lisa J. Rodriguez (argued) (Schnader Harrison Segal & Lewis, LLP); Joseph S. Tusa (Tusa). FOR APPELLEES: Diane A. Bettino, Mark S. Melodia (Reed Smith); Robert N. Hochman (argued) (Sidley Austin); James S.
Quest Diagnostics logo Quest Diagnostics (NYSE:DGX) has received a “BBB+” credit rating from Morningstar. The research firm's “BBB+” rating indicates that the company is a moderate default risk. They also gave their stock a three star rating. Several ...
Health Gorilla Inc. announced today that the Health Gorilla Online Healthcare Marketplace is certified as a Silver Quality Solution by Quest Diagnostics under Quest's Health IT Quality Solutions™ Program (the "Program"). Quest Diagnostics is the world ...
Quest Diagnostics' (DGX - Analyst Report) second-quarter 2014 adjusted earnings per share (EPS) from continuing operations of $1.08 exceeded both the Zacks Consensus Estimate and the year-ago number by 1.9% or a couple of cents. Adjusted EPS in ...
Leading diagnostic information services provider Quest Diagnostics Inc. (DGX - Analyst Report) recently introduced in vitro diagnostics major bioMerieux's companion diagnostic test, THxID(R)-BRAF to advance precision medicine for melanoma. According to ...
On May 16, 2014, we issued an updated research report on Quest Diagnostics, Inc. (DGX - Analyst Report) – a major commercial laboratory services provider. The current market environment continues to pose challenges in the form of lower healthcare ...
"We pride ourselves on prompt delivery, outstanding Customer Service and affordable rates, added Jimmy Parker, CEO of STAT Courier Services. 'While we are a private courier service, we are also the best example of a big city business with small town ...
Quest Diagnostics Inc. (DGX - Analyst Report) has signed a definitive agreement to acquire Summit Health - a leading provider of on-site prevention and wellness programs, primarily for employers. However, terms of the transaction have not been disclosed.
With the declaration of the closure of its earlier announced acquisition of Solstas Lab Partners Group and its subsidiaries, Quest Diagnostics Inc. (DGX - Analyst Report) also raised its 2014 financial outlook. With the completion of the aforesaid ...
Quest Diagnostics' (DGX - Analyst Report) fourth-quarter 2013 adjusted earnings per share (EPS) from continuing operations of $1.03 surpassed the Zacks Consensus Estimate by 9.6% and the year-ago earnings by 2%. The adjusted EPS in the reported ...
ConVerge Diagnostic is a regional leader in women's health with good repute for Customer Service, medical expertise and innovation. It provides clinical, cytology and anatomic pathology testing services to patients, physicians and hospitals in New England.
Together, Water Street and the company's management team expanded ConVerge's test menu and capabilities, particularly in the area of women's health, and invested in initiatives to enhance Customer Service. They also partnered with leading universities, ...
"As a regional leader in women's health that is also recognized for Customer Service, medical expertise and innovation, ConVerge is a strong strategic fit with our business. The addition of ConVerge to the Quest family will extend the range of ...
Quest Diagnostics Inc., the biggest U.S. operator of medical labs, and Laboratory Corp. of America Holdings defrauded Virginia's Medicaid program by billing it at higher rates than other customers, according to a 2007 state whistle-blower lawsuit ...
A unit of scientific-instrument giant Danaher (DHR) has agreed to pay $300 million for the HemoCue unit of Quest Diagnostics (DGX), Quest announced early Monday. Quest originally announced its plans to sell HemoCue, which makes blood-testing systems ...
Stocks fall sharply as traders focus on Spain · Credit card case costs Chase $100 million · Wells Fargo's Customer Service angers bank analyst · Wal-Mart opposed to $6 billion card fee deal · Amazon offers workers chance to work elsewhere · When eBay ...
The announcement of Quest Diagnostics' (DGX - Analyst Report) first quarter of fiscal 2012 results on April 18, 2012 prompted mixed estimate revisions analysts. First Quarter Highlights Quest Diagnostics reported EPS of 99 cents in the first quarter of ...
Some of the areas around which teams are organized include: specimen acquisition, which includes all the costs associated with obtaining and transporting samples; client support, which includes billing and Customer Service; the labs themselves and all ...
As such, EBITDA margin compressed by 90 basis points to 21.8% as increased investment has been dedicated to improving Customer Service levels offset by ongoing cost reduction efforts since 2007. In 2010, Quest twice reduced headcount to manage expenses ...
The company uses information systems extensively in all aspects of its business including clinical laboratory testing, test reporting, billing, Customer Service, logistics and management of medical data. The company had capital expenditure of ...
This slowdown in higher margin testing demand, coupled with increased investment dedicated to improving Customer Service levels, contributed to a 90 basis point compression of EBITDA margin, to 21.8% in 2010, and Fitch estimates a incremental 60 basis ...
Quest Diagnostics stock price target raised to $115 from $102 at Canaccord Genuity. Quest Diagnostics stock price target raised to $115 from $102 at Canaccord Genuity. Apr. 24, 2017 at 9:07 a.m. ET; by Tomi Kilgore ...
